Latest Posts
Search for:
Author

Nandu Machiraju

Browsing
Nandu Machiraju is a partner in Baker McKenzie's North America Antitrust & Competition Practice Group. He has significant industry experience in antitrust matters affecting the healthcare, pharmaceuticals, chemicals, mining, and technology sectors. Nandu advises clients on a wide range of antitrust matters and has considerable experience counseling clients in government investigations, proposed mergers and acquisitions, conduct matters, compliance, and litigation. Nandu also advises clients on other US Federal Trade Commission (FTC) matters including consumer protection and general FTC adjudicative and rulemaking issues. Nandu advises clients on all aspects of the antitrust regulatory and litigation process. He has investigated and litigated cases in industries ranging from healthcare, pharmaceuticals, medical devices, chemicals, cement, and mining. He also has developed significant experience in technology markets.
In FTC

United States: FTC puts companies on notice that failure to provide support for their product claims could result in civil penalties

by , , , and 3 Mins Read

In brief On 13 April 2023, the Federal Trade Commission (FTC) issued a letter containing a Notice of Penalty Offenses Concerning Substantiation of Product Claims to approximately 670 advertisers, putting each company on notice that deceiving consumers with advertisements that make unsubstantiated product claims could subject the company to civil penalties of up to USD 50,120 per violation under 15 U.S.C. § 45(m)(1)(B). The FTC noted that, while the initial distribution of the Notice was specific to those making…